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Abstract 
Background: Breastfeeding has protective effects for the development of allergies and atopy. Recent evidence 
underlines that consumption of unboiled farm milk in early life is a key factor preventing the development of atopic 
diseases. Farm milk intake has been associated with increased demethylation of FOXP3 and increased numbers of 
regulatory T cells (Tregs). Thus, the questions arose which components of farm milk control the differentiation and 
function of Tregs, critical T cell subsets that promote tolerance induction and inhibit the development of allergy and 
autoimmunity.
Findings: Based on translational research we identified at least six major signalling pathways that could explain 
milk’s biological role controlling stable FoxP3 expression and Treg differentiation: (1) via maintaining appropriate 
magnitudes of Akt‑mTORC1 signalling, (2) via transfer of milk fat‑derived long‑chain ω‑3 fatty acids, (3) via transfer of 
milk‑derived exosomal microRNAs that apparently decrease FOXP3 promoter methylation, (4) via transfer of exoso‑
mal transforming growth factor‑β, which induces SMAD2/SMAD3‑dependent FoxP3 expression, (5) via milk‑derived 
Bifidobacterium and Lactobacillus species that induce interleukin‑10 (IL‑10)‑mediated differentiation of Tregs, and (6) 
via milk‑derived oligosaccharides that serve as selected nutrients for the growth of bifidobacteria in the intestine of 
the new born infant.
Conclusion: Accumulating evidence underlines that milk is a complex signalling and epigenetic imprinting net‑
work that promotes stable FoxP3 expression and long‑lasting Treg differentiation, crucial postnatal events preventing 
atopic and autoimmune diseases.
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Background
Children who grow up on traditional farms are pro-
tected from atopic diseases [1]. Early-life consumption of 
unboiled cow’s milk has been identified as the most pro-
tective factor for the development of atopy [2–10]. Farm 
milk exposure has been associated with increased num-
bers of CD4+CD25+FoxP3+ regulatory T cells (Tregs), 
lower atopic sensitization and asthma in 4.5-year-old 
children [11]. Treg cell numbers are negatively associated 
with asthma and perennial immunoglobulin E serum lev-
els [11]. However, the allergy-preventive effectors of milk, 
which stimulate the development of Tregs remain elusive. 
Based on translational research we provide six potential 
milk-derived signalling pathways that could promote 
appropriate differentiation and maturation of Tregs.
Findings
Amino acids
Milk is the postnatal nutritional environment of all 
mammals that mediates immune stimulatory functions, 
especially long-term stable expression of FoxP3, the 
key transcription factor of Tregs. Milk protein provides 
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acids such as essential branched-chain amino acids that 
induce the secretion of insulin as well as amino acids 
such as tryptophan that increase hepatic insulin-like 
growth factor-1 (IGF-1) secretion [12–21]. Both growth 
hormones synergistically activate the phosphoinosite-3 
kinase (PI3K)-Akt pathway. Control of PI3K in Treg 
cells is essential for Treg lineage homeostasis and stabil-
ity [22, 23]. Diminished control of PI3K activity in Treg 
cells reduces expression of the interleukin-2 (IL-2) recep-
tor α subunit CD25, accumulation of FoxP3+CD25− cells 
and, ultimately, loss of expression of the transcription 
factor FoxP3 in these cells [23]. Excessive postnatal pro-
tein intake via infant formula feeding has been demon-
strated to increase infant’s serum levels of insulin and 
IGF-1 accelerating growth and weight gain (early protein 
hypothesis) [24–26]. Rapid weight gain in infancy has 
been linked to an increased risk of asthma [27–29].
Tregs are a developmentally and functionally distinct T 
cell subpopulation that is engaged in sustaining immuno-
logical self-tolerance and homeostasis. The transcription 
factor FoxP3 plays a key role in Treg development and 
function [30–33]. There is accumulating evidence that 
insufficient maturation and differentiation of Tregs play a 
key role in the development of common allergic diseases 
and autoimmunity [34–39].
Notably, FoxP3 expression is linked to nutrient sig-
nalling via Akt-mediated phosphorylation of the 
transcription factors FoxO1 and FoxO3. Increased insu-
lin/IGF-1 signalling leads to inactivation of FoxO1 and 
FoxO3a by their phosphorylation-dependent extru-
sion form the nucleus into the cytoplasm. Both FoxO1 
and FoxO3a exert stimulatory effects on FoxP3 expres-
sion [40] (Fig.  1). A FoxO3a-binding motif is present in 
the proximal region of the FOXP3 promoter [40]. The 
absence of FoxO1 severely curtails the development of 
FoxP3+ Tregs. In addition, the absence of FoxO3 exacer-
bates the effects of the loss of FoxO1 [41]. Thus, there is 
compelling evidence that increased PI3K-Akt-signalling 
blocks FoxP3 expression by sequestering FoxO factors 
[42]. FoxO transcription factors cooperatively control the 
differentiation of FoxP3+ Tregs [43]. FoxO proteins func-
tion in a Treg-intrinsic manner to regulate thymic and 
TGF-β-induced FoxP3 expression, in line with the abil-
ity of FoxO proteins to bind to FOXP3 locus and control 
FOXP3 promoter activity [43]. FoxO proteins are con-
sidered to play crucial roles in specifying the Treg cell 
lineage [43]. Genome-wide analysis of FoxO1 binding 
sites reveals ~300 FoxO1-bound target genes that do not 
seem to be directly regulated by FoxP3. These findings 
show that the evolutionarily ancient Akt-FoxO1 signal-
ling module controls a genetic program indispensable for 
Treg cell function [44].
Upregulated PI3K-Akt signalling in the presence of 
sufficient amounts of branched-chain amino acids and 
Fig. 1 Synoptic working model for milk‑induced FoxP3 expression and regulatory T cell (Treg) differentiation. The transcription factors FoxO1, 
FoxO3a, SMAD3 and STAT3 all enhance FoxP3 expression. Milk exosomal microRNAs and TGFβ attenuate DNA methyltransferase (DNMT) expression 
promoting TSDR demethylation (AAs: amino acids; ω3‑FAs; ω‑3 fatty acids; HMO: human milk oligosaccacharides; I: insulin; IGF1: insulin‑like growth 
factor‑1; miRs: microRNA‑148a, microRNA‑29, microRNA‑21; mTORC1: mechanistic target of rapamycin complex 1; TGFβ: transforming growth 
factor‑β; STAT3: signal transducer and activator of transcription 3; TSDR: Treg‑specific demethylated region)
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glutamine increases the activity of the nutrient-sensi-
tive kinase mechanistic target of rapamycin complex 1 
(mTORC1) [45–47]. Milk has recently been identified 
as a signalling system of mammalian evolution control-
ling mTORC1-dependent translation [48, 49]. Enhanced 
mTORC1 activity was found in the brain and ileum of 
mice with cow’s milk allergy (CMA) [50]. Treatment with 
the mTORC1 inhibitor rapamycin significantly increased 
the mRNA expression of FoxP3 in the ileum and Peyer’s 
patches of CMA mice. A correlation between the extent 
of mTORC1-mediated S6K1 phosphorylation and FoxP3 
mRNA expression in the ileum was demonstrated [50].
Taken together, the Akt-mTORC1 axis controls FoxP3 
expression and differentially regulates effector and Treg 
cell linage commitment [43, 51–53]. It is thus conceivable 
that a well-balanced transfer of critical amino acids via 
breastfeeding controls Akt-mTORC1-mediated Treg dif-
ferentiation, which may be disturbed by artificial formula 
feeding with high protein content [54, 55].
Long‑chain ω‑3‑fatty acids
Part of the asthma-protective effect is associated with 
the intake of raw cow’s milk and was explained by higher 
levels of polyunsaturated ω-3 fatty acids of farm milk 
[56]. Remarkably, it has been demonstrated in a mouse 
model of atopic dermatitis that administration of the ω-3 
fatty acid docosahexaenoic acid upregulates the genera-
tion of TGF-β-dependent CD4+ Foxp3+ Tregs [57, 58]. 
Furthermore, fatty acids play a role in mTORC1 activa-
tion. Whereas the saturated fatty acid palmitate activates 
mTORC1, the ω-3 fatty acid eicosopentaenoic acid inhib-
its mTORC1 activation [59]. Thus, ω-3-fatty acids may 
not only attenuate pro-inflammatory eicosanoid biosyn-
thesis but may exert direct effects on FoxP3 Treg activity. 
In fact, it has been demonstrated that Tregs transfer ω-3 
long chain polyunsaturated fatty acids-induced tolerance 
in mice allergic to cow’s milk protein [60].
MicroRNAs
Extracellular RNAs and especially exosomal microR-
NAs are regarded as most important factors involved in 
the regulation of the immune system [61, 62]. Human 
breast milk is a body fluid that is highly enriched in 
mRNAs and microRNAs [63]. MicroRNAs are either 
packaged with proteins (i.e. Ago2, HDL, and other 
RNA-binding proteins or wrapped in small membra-
nous particles (i.e. exosomes, microvesicles, and apop-
totic bodies) [64–67]. Human, bovine and porcine milk 
transfer high numbers of exosomes that contain micro-
RNAs [68–70]. Recent evidence indicates that human 
milk microRNAs primarily originate from the mammary 
gland resulting in unique microRNA profiles of frac-
tionated milk [71]. Recently, we hypothesized that milk 
transmits microRNAs (microRNA-155, microRNA-148a, 
microRNA-29b, microRNA-21) that may induce thymic 
FoxP3+ Treg differentiation thereby preventing the devel-
opment of allergy [72]. Indeed, farm milk consumption is 
associated with higher FOXP3 demethylation and higher 
Treg cell numbers [11]. Stable expression of FoxP3 in 
Tregs depends on DNA demethylation at the Treg-spe-
cific demethylated region (TSDR), a conserved CpG-
rich region within the FOXP3 locus [73–75]. In contrast, 
hypermethylation of the FOXP3 gene has been associated 
with reduced Treg function and allergy [76, 77]. Notably, 
atopic individuals express lower numbers of demethyl-
ated FoxP3+ Tregs [78].
There are two potential mechanisms of DNA dem-
ethylation: (1) passive demethylation through inhibi-
tion of DNA methyltransferases (DNMTs) and (2) active 
demethylation mediated by ten-eleven-translocation 
(TET) 2 and 3 [79]. TET2 binding to CpG-rich regions 
requires the interaction of TET2 with the protein IDAX 
(also known as CXXC4) [80]. Intriguingly, the CXXC 
DNA-binding domains can bind unmethylated DNA and 
recruit TET2 via IDAX [81]. Thus, DNMT inhibition may 
favour active TET2-mediated TSDR demethylation.
Both DNMT1 and DNMT3b are associated with the 
FOXP3 locus in CD4+ cells [82, 83]. Remarkably, DNMT1 
deficiency resulted in highly efficient FoxP3 induction fol-
lowing TCR stimulation [82]. Importantly, DNMT1 is a 
direct target of microRNA-148a [84], which is abundant in 
bovine colostrum, mature cow’s milk, and human breast 
milk [68, 85, 86]. MicroRNA-148a is highly expressed in 
bovine milk fat and milk fat globules of human breast 
milk [87, 88]. MicroRNA-148a directly downregulates 
the expression DNMT1 and DNMT3b, whereas micro-
RNA-21, another abundant microRNA of cow’s milk, 
indirectly inhibits DNMT1 expression by targeting RAS-
GRP1 [84]. MicroRNA-29b increases dose-dependently 
in human serum after intake of pasteurized cow’s milk 
[89]. MicroRNA-29 targets DNMT3a and DNMT3b [90]. 
Remarkably, nucleotide sequences of microRNA-148a-3p, 
microRNA-29b and microRNA-21 of Homo sapiens and 
Bos taurus are identical (mirbase.org). Kirchner et al. [87] 
recently suggested that microRNAs of unprocessed cow’s 
milk mediate the allergy preventive farm milk effect. It is 
of functional importance that most milk-derived microR-
NAs are transported either in exosomes or milk fat glob-
ules [48, 49, 69, 70, 88–93].
It has recently been demonstrated that bovine milk 
microRNAs (microRNA-29b, microRNA-200c) are taken 
up in reasonable amounts by healthy human subjects 
after consumption of pasteurized cow’s milk [88]. Further 
evidence underlines that bovine milk exosomes are able 
to cross human intestinal cells and vascular endothelial 
cells via endocytosis [94, 95].
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Notably, boiling of raw cow’s milk abolishes the allergy-
preventive farm milk effect [3] and results in substantial 
loss of microRNA-148a-3p [87]. MicroRNA-155, another 
important immune regulatory microRNA of milk [72], 
targets suppressor of cytokine signalling 1 (SOCS1), 
which maintains STAT5 activity further enhancing Treg 
differentiation [96]. Boiling of milk may disrupt the pro-
tective lipid bilayer of milk exosomes accelerating the 
degradation of critical milk microRNAs. Furthermore, 
heat-induced alterations of exosomal membrane proteins 
may disturb intestinal exosome uptake. Thus, native milk-
derived exosomal microRNAs via suppressing DNMTs 
may provide pivotal epigenetic signals stabilizing FoxP3 
expression and Treg differentiation.
Exosomal transforming growth factor‑β
It has been demonstrated that exosomes of cow’s milk 
not only transfer microRNAs but also transforming 
growth factor-β (TGF-β) [97]. The TGF-β signalling 
pathway activates the transcription factors SMAD2 and 
SMAD3 [98, 99]. SMAD3 is a crucial transcription fac-
tor enhancing FoxP3 expression via binding to the con-
served non-coding sequence 1 (CNS1) of FOXP3 [100] 
(Fig.  1). Experimental evidence reveals that TGF-β in 
the context of T cell receptor (TCR) stimulation induces 
FoxP3 gene transcription in thymic Treg precursors, 
CD4+ CD8− CD25− semimature and mature single-
positive thymocytes [101]. TGF-β also converts naïve 
T cells into inducible Treg (iTregs) and protects Tregs 
against apoptosis and destabilization [102]. Importantly, 
it has been demonstrated that TGF-β-induced expres-
sion of FoxP3 in T cells is mediated through inactivation 
of the kinase ERK [103]. TGF-β via inhibition of ERK 
activation downregulates the expression of DNMT1, 
DNMT3a and DNMT3b associated with increased FoxP3 
expression [97]. Recently, Arntz et  al. [104] confirmed 
that bovine milk exosomes induce FoxP3 expression and 
Treg differentiation in murine splenocytes. Thymus-
derived exosomes as well are able to induce FoxP3+ 
Tregs in peripheral tissues [105]. Moreover, the incuba-
tion of peripheral blood mononuclear cells with isolated 
human breast milk exosomes increased the number of 
FoxP3+CD4+CD25+ Tregs [106]. Thus, milk-derived 
exosomal TGF-β acts via transcriptional control and epi-
genetic regulation of FoxP3 expression. It is noteworthy 
to mention that deficient TGF-β signalling is associated 
with activation of the PI3K/Akt pathway [107], which 
suppresses FoxO signalling.
Bifidobaceria and lactobacilli
Human milk is a source of living bifidobacteria and lac-
tobacilli for the infant gut [108–111]. Bifidobacterium 
breve, B. adolescentis, B. bifidum, and Lactobacillus 
plantarum WLPL04 were isolated from human milk 
samples [108, 110]. There is accumulating evidence that 
probiotic bacteria generate FoxP3 T-cell responses in the 
small intestine [112]. L. plantarum WCFS1, L. salivarius 
UCC118, and L. lactis MG1363 upregulate numbers of 
CD11c+ MHCII+ dendritic cells in the immune-sam-
pling Peyer’s patches [112]. L. plantarum, L. salivarius, 
and L. lactis attenuate Th2 responses and increase Treg 
frequencies in healthy mice in a strain dependent man-
ner [113]. Oral consumption of Bifidobacterium infantis 
35624 enhanced IL-10 secretion and FoxP3 expression in 
human peripheral blood cells pointing to the immune-
stimulatory effect of bifidobacteria on FoxP3+ iTreg 
induction [114, 115]. Furthermore, it has been demon-
strated that bifidobacteria stimulate TGF-β, which con-
tributes to Treg differentiation [116].
Special attention has been paid on the critical role of the 
anti-inflammatory cytokine IL-10 in probiotica-induced 
anti-inflammatoy intestinal immune responses [110, 117, 
118]. Despite heat-killing, Lactobacillus pentosus strain 
S-PT84 exhibited anti-allergic effects by modulating the 
Th1/Th2 balance and inducing Tregs [119]. Live and heat-
killed Lactobacillus rhamnosus suspensions were able to 
induce the synthesis of different cytokines including IL-10 
[120]. Heat-killed Lactobacillus acidophilus strain L-92 
produced higher levels of Foxp3, IL-10 and TGF-β com-
pared to control mice and suppresses allergic contact der-
matitis [121]. In a bovine β-lactoglobulin-sensitized mice 
model, oral administration of heat-killed L. acidophi-
lus exhibited increased mRNA expression of Foxp3 and 
TGF-β [122]. It should be noticed, that heat-treatment 
of probiotics may also result in a loss of immune-regu-
latory functions. However, the majority of studies using 
either native or heat-treated bifididobacteria or lactoba-
cilli exhibits an upregulation of IL-10, TGFβ and FoxP3 
[116, 119–122]. Remarkably, IL-10 potentiates differen-
tiation of human induced Tregs via STAT3 and FoxO1 
[123]. Hsu et al. [123] demonstrated that the presence of 
IL-10, in addition to TGF-β, leads to increased expan-
sion of Foxp3+ iTregs with enhanced CTLA-4 expression 
and suppressive capability, comparable to that of natural 
Tregs. This process is dependent on IL-10R-mediated 
STAT3 signalling. Additionally, IL-10-induced inhibition 
of Akt phosphorylation and subsequent preservation of 
FoxO1 function are critical. In contrast to formula feed-
ing, the presence of maternal milk in β-lactoglobulin-
sensitized rat pups exhibited an immune response profile 
similar to that of unchallenged dam-reared rats but with 
greater FoxP3 mRNA expression and CD4+ FoxP3+ cells 
[124]. These data may explain the preventive effect of pro-
biotics for sensitization to common food allergens associ-
ated with a reduced incidence of atopic eczema in early 
childhood [125]. However, due to a lack of well-designed 
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studies convincing evidence for the prevention of aller-
gic asthma by probiotic treatment is still missing [126, 
127]. The time of onset of probiotic exposure, which is 
physiologically natural birth and the period of breastfeed-
ing, may play critical roles for probiotica-induced Treg 
maturation.
Milk oligosaccharides
Human milk contains large amounts of free oligosac-
charides (HMOs). HMOs have been shown to exert 
anti-inflammatory properties, and evidence for their 
immune-modulatory effects is increasing [128–130]. A 
growing literature suggests that human milk contains 
viable bacteria [131]. McGuire et  al. [131] postulated 
that human milk should be regarded as a probiotic food. 
Human milk oligosaccharides (HMOs) are minimally 
digested by the infant and are utilized by bifidobacteria 
[132]. One postulated function for these oligosaccha-
rides is to enrich a specific “healthy” microbiota contain-
ing bifidobacteria, a genus commonly observed in the 
faeces of breastfed infants [133]. Recent studies show 
that some species of bifidobacteria are equipped with 
genetic and enzymatic sets dedicated to the utilization 
of HMOs promoting HMO-dependent growth of bifi-
dobacteria [134]. Among gut microbes, the presence 
of enzymes required for degrading HMOs with type-1 
chains is essentially limited to infant-gut-associated bifi-
dobacteria, suggesting HMOs serve as selected nutri-
ents for the bacteria pointing to a co-evolution between 
bifidobacteria and human beings mediated by HMOs 
[135]. Formula feeding in comparison to breastfeeding 
compromises the development of the physiological gut 
microbiome. In breastfed Rhesus infants Bifidobacteria 
and Lactobacillus predominated, whereas in formula-fed 
infants Ruminococcus was predominant [26]. Breastfed 
human infants harbour a faecal microbiota more than 
twice increased in Bifidobacterium numbers compared to 
formula-fed infants [136]. After formula feeding, Atopo-
bium was found in significant counts and the numbers 
of Bifidobacteria dropped followed by increasing num-
bers of Bacteroides population [136]. Infant formulas 
containing non-digestible oligosaccharides similar to 
the composition in breast milk or a combination of lac-
tic acid bacteria have been shown to harbour preventive 
effects towards immune-regulatory disorders [137, 138]. 
In fact, recent studies with whey and casein-sensitised 
mice showed that CD25+ Treg contribute to the suppres-
sion of the allergic effector response in sensitised mice 
induced by dietary intervention with non-digestible car-
bohydrates [139, 140]. Thus, it appears that milk is mam-
mal’s early life probiotic nutrient system supporting and 
maintaining Bifidobacteria and Lactobacillus species that 
induce Tregs and control immune responses.
Conclusions
Compelling evidence underlines that milk is not a simple 
food for infants but represents a sophisticated signalling 
network that promotes the differentiation and long-last-
ing maintenance of Tregs, the central players suppress-
ing the development of allergy and autoimmunity. Milk 
provides an intricate metabolic, epigenetic, probiotic and 
stem cell-derived system that induces stable expression 
of FoxP3, the master transcription factor of Tregs. The 
critical allergy-preventive factor in cow’s milk appears to 
be heat-sensitive and is abolished by boiling of milk. As 
amino acids and the majority of long-chain ω-3 fatty acids 
withstand the boiling process, heat-sensitive compounds 
such as milk exosomes, probiotic bacteria and stem cells 
are the potential candidates for long-lasting Treg differ-
entiation. In more than 200,000 million years of lacta-
tion [141, 142] the evolution of milk had plenty of time 
to create a sophisticated regulatory network optimiz-
ing the infant’s Treg differentiation allowing appropriate 
tolerance development during the postnatal period of 
mammalian life. In this regard, unprocessed milk should 
be regarded as a conditioner for tolerance development. 
After birth, the newborn’s immune system encounters 
foreign environmental antigens such as nutrients, pollens 
and house dust mite allergens, which via antigen-specific 
TCR-mediated activation induce antigen-specific Tregs. 
The milk-related signalling pathways presented here, may 
in a synergistic manner enhance antigen-specific Treg 
generation associated with the induction of allergen-spe-
cific immune tolerance (Fig. 1).
Most recent data underline that developing natural 
Treg (nTreg) cells in the thymus acquire a Treg-specific 
and stable hypomethylation pattern in a limited num-
ber of genes, which encode key molecules including 
FoxP3, essential for Treg cell function. This epigenetic 
change is acquired via TCR stimulation, beginning prior 
to FoxP3 expression. The Treg-specific DNA hypometh-
ylated regions generally act as gene enhancers in steady 
state nTreg cells, contributing to the stable expression of 
Treg function-associated key genes including Ctla4, Il2ra, 
and Ikzf4 in addition to FoxP3 [143, 144]. Recent work 
suggests that the establishment and stability of Tregs is 
mediated by a number of mechanisms besides FoxP3 
expression, such as epigenetic modifications, FoxO1, 
FoxO3a localization, expression of Eos and signalling via 
Neuropilin-1 [143]. To understand the pathogenesis of 
allergy development it is most important to characterize 
the immune regulatory networking of native milk. Future 
studies should thus focus on natural unprocessed milk 
and its regulatory mechanisms that support long-lasting 
stability of Tregs mediating livelong tolerance induction 
against harmless environmental antigens and autoanti-
gens [145, 146]. We are at the beginning to understand 
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the complex interplay of milk’s regulatory factors induc-
ing and stabilizing the infant’s FoxP3 expression. Yet, we 
have no idea about the functional priority of milk-derived 
factors involved in Treg lineage commitment. It is thus 
prudent to rely on the regulatory effectiveness of our 
own lactation genome, which co-evolved with the lacta-
tion-associated microbiome. Therefore, we recommend 
breastfeeding for adequate Treg maturation and the pre-
vention of allergic diseases of human infants. However, 
for mothers who are not able to provide breast milk, 
human donor milk might be an alternative for appropri-
ate Treg differentiation. Countrywide access to operating 
human milk banks in East Germany before Germany’s 
unification in 1990, may explain the lower prevalence 
rates of atopic diseases in East versus West Germany 
[147, 148]. Artificial formulas still substantially differ 
from human breast milk. If milk exosomal microRNAs 
play a key role in Treg differentiation, it is of critical con-
cern that current infant formula only contains very few 
human lactation-specific microRNAs [149]. The addition 
of bovine milk exosomal microRNAs may represent a 
future improvement of artificial formula feeding. Due to 
legal aspects and the risk of pathogen transfer, raw cow’s 
milk can not be recommended as an agent for allergy pre-
vention. However, in the future, it might be possible to 
prepare sterilized bovine milk exosomes for this purpose. 
It has already been shown that bovine milk exosomes 
increased Foxp3 expression and attenuated arthritis in 
two mouse models [104].
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